the new 15-membered semi-synthetic macrolide antibiotic with nitrogen as additional atom in the aglycone ring of erythromycin A (1), was reported. Although amine (5) and its 13,14-cyclic carbonate (14) were less active than 1 against erythromycin-sensitive Staphylococcus aureus strains they showed advantageous properties against Gram-negative test organisms and clinical isolates. Also, a large number of acyl derivatives of 5 were synthesized and evaluated. N-ll monoacyl compounds exhibited 2 to 50 times lower in vitro antibacterial efficacy than the parent amine (5).
Erythromycin A (1)1} is a well known antibiotic that is clinically useful against infections of Grampositive bacteria and mycoplasmas. However, it is weakly active against Grarn-negative bacteria and is particularly unstable toward acids. Efforts to improve on the latter have led to oximation of 1 with hydroxylamine to afford C-9 oxime (2)2»3) which on hydrogenation yields 9GS)-erythromycylamine (3) as the major component and the minor 9(i?)-epimer (4)4). Compounds 2 and 3 exhibited about 50% of the biological potency of 12»4), but amine (3) indicates a trend toward higher Gram-negative in vitro antibacterial activity (Table 4) . Kinetic study of acid-catalyzed hydrolysis of 2 and 3 revealed better acid stability than 15). With the view of further improvement of antibacterial and physico-chemical properties, we studied the Beckmannrearrangement of 26) and its acid addition salts, especially erythromycin A oximemono-and dihydrochlorides7). The rearrangement with /?ara-substituted arene sulfonyl In this paper, we report the antimicrobial evaluation of 5. The synthesis, structure elucidation and in vitro antibacterial activities of its N-, O-and JV,0-acyl derivatives are also discussed.
Chemistry
Treatment of amine (5) with acetic anhydride in pyridine at room temperature for 30 minutes, similar to the conditions used for the synthesis of 2'-esters of 19~12), gave the diacetyl derivative (9) The 13C NMRspectra were taken with Jeol 90 Q spectrometer. Samples were dissolved in CDC13or DMSOcontaining TMSas an internal standard. Table   2 ). The IR spectrum showed an amide carbonyl band at 1620cm"1 indicating that one of the acetyl groups was located at N-l1. The electron impact mass spectra (EI-MS) (Table 3 ) gave the molecular ion at mjz 818. Prominent fragments at mjz 659 and 618 formed by glycosidic cleavage of cladinose (m/z 159) and desosamine (m/z 200) suggested that the other acyl group was at 2'-position13). Finally, the downfield chemical shifts of C-2' and C-4' and an up field shift of C-3' carbon were compatible with the known data for 2'-acylation of erythromycins14). Methanolysis of diacetyl (9) developed for the removal of 2/-O-acetyls15»16), followed by silica gel column chromatography, produced Medium: Heart infusion, pH 7.2. Inoculum: One loopful of bacterial suspension (about 108 cells per 1 ml).
Incubation: 20 hours at 37°C.
homogeneous monoacetyl (8) . The strong band at 1610 cm"1 in the IR spectrum and increased pKvalue (8.6) in comparison with 9 (pK7.1)15> indicated 8 to be ll-JV-acetyl-10-dihydro-10-deoxo-llazaerythromycin A. Furthermore, comparison of 13C NMRspectra of amine (5) and monoacetyl (8) showed that the chemical shifts assigned to desosamine moiety were nearly identical. Extended treatment of 5 with acetic anhydride in pyridine yielded a new ester (10) with three acetyl singlets at 2.078, 2.029 and 2.103 ppm in the^NMRspectrum and the molecular ion at m/z 860 in the mass spectrum. Consistent with the location of the new acyl group at 4"-OH, the fragments due to the cleavage of cladinose with or without glycosidic oxygen at m/z 159 and 175 increased by 42 mass units leading to fragments m\z 201 and 217, respectively. Vigorous acetylation of amine (5) by heating in a pyridine solution with acetic anhydride at 70°C gave a tetraacetyl (ll) with m/z 902 (M+). ll-JV-
synthesized in a similar manner using propionic anhydride. To prepare mono-(6) and diformate (7) formic acetic anhydride as formylating reagent was employed16). Their structures were ascertained principally by the combination of mass spectrometry and XHand 13C NMRspectroscopy. The reaction of 5 with ethylene carbonate17*18) yielded 13,14-cyclic carbonate (14) . The carbonate carbonyl band in the IR spectrum appeared at 1790 cm"1 and the mass spectrum gave a molecular ion NMRspectrum of 15 revealed only three acetyl methyls at 2.095, 2.053 and 2.108 ppm. Thus, engagement of the C-13 hydroxyl in the formation of the carbonate ring precludes formation of a tetraacetyl derivative in this case. Antibacterial Activity The ring-expansion of the 14-memberedaglycone of 1 and the introduction of the secondary amino group leading to 5 resulted in decrease of in vitro biological potency. By a standard diffusion method using Micrococcus luteus ATCC9341 as the test strain, the amine (5) exhibited about 67 % (607 u/mg) of the activity of 1 but it was more potent in comparison with C-9 oxime (2). Contrary to the observations of Bojarska-Dahling et al.19\ trans-esterification of ethylene carbonate with amine (5) leading to desired 13,14-cyclic carbonate (14) did not increase the activity (577 u/mg).
The minimuminhibitory concentrations (MICs) of 5 and 14 against variety of Gram-positive and Gram-negative bacteria using erythromycin A (1), C-9 oxime (2) and 9(S)-erythromycylamine (3) as reference compoundsare shownin Table 4 . Against erythromycin-sensitive Staphylococcus aureus strains the in vitro activity of 5 and its 13,14-cyclic carbonate (14) was lower than that of 1. However, clinically isolated Gram-negative bacteria (Table 5 ). In concentrations of 0.5 to 4.0^g/ml amine (5) inhibited 52 (29 %) strains, whereas the parent antibiotic (1) was active only against 6 (3.4 %) clinical isolates. However, this substantial increase of in vitro efficacy of 5 was not enough to render it useful, invivo20).
Acylation of the secondary amine (5) decreased the in vitro activity. 7V-Monoacyl derivatives (6, 8 and 12) exhibited antibacterial efficacy 2 to 50 times lower than that of 5 ( Table 6 ). The introduction of the second acyl group, as demonstrated for the diacetyl (9) in comparison with iV-acetyl derivative (8) , resulted in little or no change of in vitro potency. Similar findings were previously reported for mono-and diacyl derivatives of C-9 oxime (2)21). Furthermore, the activity of multiesters decreased with increasing the chain length and the number of acyl groups.
In conclusion, the in vitro antibacterial activities of the new semi-synthetic macrolide antibiotics were somewhat less than those of erythromycin A (1) against Gram-positive bacteria. On the other hand, amine (5) and its 13,14-cyclic carbonate (14) showed somewhat better activity in vitro against Gram-negative strains, while iV-acylation resulted in considerably less in vitro potency. From these findings we concluded that 5 was interesting enough for further investigations.
Encouraging results which have been obtained with iV-alkyl derivatives of S22) will be published in our succeeding paper. One of these, iV-methyl derivative of 5 is under developement as DCH3, XZ-450 or CP-62,993.
Exp erimental
Melting points were taken using Fisher-Johns apparatus and are uncorrected. IR spectra were recorded using Perkin-Elmer 256 G spectrometer. Mass spectra were measured on a CEC21~110 C spectrometer at 70 eV. TONMRspectra were recorded with Jeol FX-100 spectrometer in CDC13and chemical shifts are given in ppmrelative to TMSas an internal standard. 13C NMRspectra were determined with Jeol 90 Q spectrometer in CDC13or DMSOsolutions. Thin-layer chromatography (TLC) was performed on Merck Kieselgel 60 F254 with CHC13 -MeOH-HCONH2(100:20:2). Silica gel column chromatography was performed with Merck Kieselgel 60. l l -A^Formyl-10-dihydro-10-deoxo-l l -azaerythromycin A (6) To a suspension of K2CO3 (1 g, 7.2 mmol) in a soln of 1.83 g (2.5 mmol) of 10-dihydro-10-deoxo-ll-azaerythromycin A (5) dissolved in Et2O (50 ml) was slowly added (30 minutes) at 0~4°C formic acetic anhydride (2.64 ml, 28 mmol). After stirring at 25°C for 3 hours the mixture was poured over ice, the Et2O layer separated and the aq layer extracted with CHC13. The combined CHC13extracts were dried (K2CO3) and evaporated to give a colorless residue, which was purified by column chromatography (CHC13 -MeOH, 7 : 3) to afford ll-A^-formyl-10-dihydro-10-deoxo-ll-azaerythromycin A (6) 1.23 g (65.1 %) as a white powder: MP 234~236°C; TLC Rf 0.292 (Table 1) ; Anal (C38H70N2O13)
To a soln of 2.45 g (3.3 mmol) of5 in pyridine (25 ml) was added at 0~4°C formic acetic anhydride (10 ml, 0.113 mol). After 30 minutes the reaction mixture was diluted with cold 5% NaHCO3soln and extracted with CHC13. The organic layer was dried over K2CO3 and evaporated to give 2.69 g of a residue which was chromatographed on a silica gel column with CHC13-MeOH(7 : 3) to give 7, 1.86 g (70.7%): MP 252~256°C; TLC Rf 0.433; Anal (C39H70N2O14) C, H, N.
To a soln of 5 (4 g, 5.4 mmol) in pyridine (20 ml), acetic anhydride (10 ml, 0.106 mol) was added and the reaction mixture allowed to stand at 25°C for 30 minutes. The soln was poured over ice, the pH of the reaction mixture adjusted with 20% NaOHto 9 and extracted with CHC13. The CHC13 layer was washed with 5% NaHCO3 (50ml) and H2O (25 ml). After drying (K2CO3), CHC13 was evaporated to yield 4.7 g of a glassy solid which was chromatographed over silica gel column with CHC13-MeOH-NH4OH (6:1 :0.1) to give 9, 3.24g (72.7%):
MP 132-134°C; TLC Rf0.567; Anal (C41H74N2O:4) C, H, N.
The diacetyl derivative (9) (1.8 g, 2.2 mmol) was dissolved in MeOH (30 ml) and the hydrolysis followed by TLC. After 7 days MeOHwas evaporated to yield 1.6 g ofa residue which was chromatographed over silica gel column with CHC13-MeOH To a stirred soln of 2.15 g (2.5mmol) of dipropionyl derivative (13) in MeOH(45ml), 5% NaHCO3soln (45 ml) was added and the reaction mixture allowed to stand at room temp for 7 days. MeOHwas evaporated, the obtained residue extracted with CHCL, the combined organic extracts washed with H2O, dried (K2CO3) and concentrated in vacuo to yield L84 g (88.8%) of ll-iV-monopropionyl derivative (12) : MP 122-129°C; TLC Rf 0.383; Anal (C40H74N2O13) C, H, N.
1 0-Dihydro-1 0-deoxo-l l -azaerythromycin A 1 3, 14-Cyclic Carbonate (14) In an EtOAc soln (240 ml) of 5 (24 g, 32.7 mmol), K2CO3 (6.4 g, 46.3 mmol) was added and then slowly during 30 minutes at reflux temp 16 g (182 mmol) of ethylene carbonate. After the addition was complete, stirring was continued for additional 24 hours at reflux temp, EtOAcevaporated in vacuo and the residue dissolved in CHC13(200 ml). H2O(200 ml) was added, the layers separated and the aq layer extracted with CHC13. The combined CHC13extracts were washed with H2O, dried (MgSO4) and then purified by precipitation from Me2CO-H2O(1 :3) (160ml). The resulting suspension was stirred at room temp for 1 hour, the product filtered off to give 19.1 g (76.9%) of 13,14-cyclic carbonate ( 3 mmol) in pyridine (10 ml), acetic anhydride (10 ml, 0.106 mol) was added and the reaction mixture left at room temp for 10 days. The soln was poured onto ice and isolated as described for 9 to yield 1.2 g of a glass which upon crystallization from Et2O -petroleum ether gave 0.75 g (64.3%): MP 128-137°C; TLC Rf0.758; Anal (C44H74N2O16) C, H, N.
